Abstract
Predicting Response to Pegylated Interferon/Ribavirin-Based Therapy in Genotype 1 Chronic Hepatitis C Patients: Results of 3 Independent Genome-Wide Association Studies
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
